Showing results (31-40 of 8,102) with videos related to

Sort By:
Pageof 811
Haematologica|August 31, 2010
Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host diseaseMelinda E Christensen, Brie E Turner, Laura J Sinfield, et al.
Haematologica|August 31, 2010
Physical activity and risk of venous thromboembolism. The Tromso studyKnut H Borch, Ida Hansen-Krone, Sigrid K Braekkan, et al.
Haematologica|September 9, 2010
Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseasesJan Rohr, Karin Beutel, Andrea Maul-Pavicic, et al.
Haematologica|September 9, 2010
p-ERK1/2 is a predictive factor of response to erythropoiesis-stimulating agents in low/int-1 myelodysplastic syndromesEmilie Frisan, Patrycja Pawlikowska, Cecile Pierre-Eugène, et al.
Haematologica|September 9, 2010
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomasScott J Rodig, Jeffery L Kutok, Jennifer C Paterson, et al.
Haematologica|September 9, 2010
Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasmsPhilip A Beer, Christina A Ortmann, Frank Stegelmann, et al.
Haematologica|January 19, 2011
MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemiaDiana Schotte, Renée X De Menezes, Farhad Akbari Moqadam, et al.
Haematologica|December 22, 2010
A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell linesJérôme Moreaux, Bernard Klein, Régis Bataille, et al.
Haematologica|December 22, 2010
Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphomaGeorge O Negrea, Rebecca Elstrom, Steven L Allen, et al.
Haematologica|October 19, 2010
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphomaNicola Gökbuget, Christina-Maria Hartog, Renato Bassan, et al.
Pageof 811